# PD-Rx Pharmaceuticals, Inc. – FDA Inspection, Aug 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/pd-rx-pharmaceuticals-inc/66259774-13a6-46b1-aa9f-25aa061606c0
Source feed: FDA_Inspections

> FDA inspection 1331942 of PD-Rx Pharmaceuticals, Inc., August 20, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1331942
- Company Name: PD-Rx Pharmaceuticals, Inc.
- Inspection Date: 2026-08-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1190289 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/pd-rx-pharmaceuticals-inc/0697b0e3-f55e-448f-ba56-c0a736beed4e)
- [FDA Inspection 955661 - 2015-12-04](https://www.keypedia.com/records/fda_inspections/pd-rx-pharmaceuticals-inc/49b01450-25db-4dab-8006-7ad8bacd7f66)
- FDA Inspection 593127 - 2009-05-21

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-t-prosterman/1343bea3-692d-484e-b29f-c9f8f052f09c)

Company: https://www.keypedia.com/companies/pd-rx-pharmaceuticals-inc/8db0dce5-ea08-4b59-9f44-286bb22f75b9

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9